title: [Treatment of pseudophakic cystoid macular edema].
abstract: Pseudophakic cystoid macular edema (PCME) is the most common complication following cataract surgery. In 1-3% of cases it is associated with a decrease in visual acuity. However, PCME has a good prognosis, persisting in only 10% of the patients beyond 2 years. The prophylactic therapy of eyes without additional disease with non-steroidal antiphlogistic drugs or steroids does not influence the final visual acuity. Under certain circumstances, prophylaxis can be a reasonable option. Risk factors that promote the formation of PCME are discussed. The course of acute or chronic PCME can be influenced by drug treatment, but in general the level of evidence for the treatment of this widespread problem is low. We would therefore like to present the Freiburg treatment scheme for PCME for discussion.
authors: Universitäts-Augenklinik Freiburg, Freiburg. hansjuergen.agostini@uniklinik-freiburg.de
authors: H T
authors: HT
authors: Agostini
authors: L L
authors: LL
authors: Hansen
authors: N
authors: N
authors: Feltgen
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D005451:Fluorescein Angiography; D006801:Humans; D007910:Lenses, Intraocular; D008269:Macular Edema / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D009883:Ophthalmic Solutions; D009887:Ophthalmoscopy; D011183:Postoperative Complications / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors; D041623:Tomography, Optical Coherence; D014821:Vitrectomy
chemical_list: D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009883:Ophthalmic Solutions